Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G. Nordestgaard(Gentofte Hospital), Anne Tybjærg‐Hansen(University of Copenhagen), Jan Albert Kuivenhoven(University Medical Center Groningen), Philippe Lesnik(Inserm), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), Lâle Tokgözoğlu(Hacettepe University), Željko Reiner, Jan Borén(Göteborgs Stads), L. Masana(Universitat Rovira i Virgili), Kausik K. Ray(Imperial College London), M. John Chapman(University of Cambridge), Gerald F. Watts(Royal Perth Hospital), Petri T. Kovanen(Wihuri Research Institute), Edward A. Fisher(Mount Sinai Hospital), Alberico L. Catapano(University of Milan), Felicita Andreotti(Agostino Gemelli University Polyclinic), Olivier Descamps(Centre Hospitalier Universitaire de Tivoli), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Henry N. Ginsberg(Columbia University)
Cited by 1,791
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k